Abstract
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To systematically review the available evidence on the effects (benefits and harms) of DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT-2 inhibitors in people with established CVD, using network meta-analysis.
Cite
CITATION STYLE
Kanie, T., Mizuno, A., Yoneoka, D., Tam, W. W. S., Morze, J., Rynkiewicz, A., … Kwong, J. S. W. (2020). Dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonists and sodium-glucose co-transporter-2 inhibitors for people with cardiovascular disease: a network meta-analysis. Cochrane Database of Systematic Reviews, 2020(6). https://doi.org/10.1002/14651858.CD013650
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
